Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
2.10T | 1.48T | 2.20T | 2.27T | 2.04T | Gross Profit |
2.10T | 1.91T | 2.20T | 2.27T | 2.04T | EBIT |
1.19T | 677.08B | 3.40T | 1.06T | 690.15B | EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
857.62B | 579.43B | 792.28B | 842.47B | 547.61B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.27T | 10.52T | 11.30T | 11.14T | 11.16T | Total Assets |
68.40T | 71.09T | 68.42T | 63.84T | 55.70T | Total Debt |
15.08T | 12.71T | 10.58T | 17.41T | 14.69T | Net Debt |
11.81T | 6.93T | 5.31T | 12.15T | 10.83T | Total Liabilities |
63.04T | 65.77T | 63.46T | 59.41T | 52.00T | Stockholders Equity |
4.29T | 5.19T | 4.85T | 4.33T | 3.62T |
Cash Flow | Free Cash Flow | |||
374.67B | 1.19T | -472.28B | -673.95B | -905.78B | Operating Cash Flow |
482.39B | 1.32T | -358.99B | -587.18B | -819.99B | Investing Cash Flow |
-106.58B | -117.85B | -94.60B | -91.77B | -70.11B | Financing Cash Flow |
-372.85B | 2.95T | -384.32B | 238.66B | 102.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $51.81B | 7.23 | 20.84% | 3.02% | 1.25% | 20.03% | |
80 Outperform | $10.00B | 6.35 | 32.82% | 4.64% | 30.54% | 97.65% | |
73 Outperform | $10.35B | 11.44 | 16.05% | 2.59% | -22.63% | 32.31% | |
70 Outperform | $20.06B | 6.87 | 10.44% | 1.58% | -8.06% | 3.79% | |
70 Outperform | $10.40B | 6.33 | 15.62% | 8.38% | 10.45% | 8.04% | |
66 Neutral | $16.15B | ― | 11.61% | 4.98% | -3.94% | ― | |
64 Neutral | $13.80B | 10.64 | 9.23% | 4.22% | 17.66% | -7.66% |